J. W. J. Bijlsma
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update
2013/10/25 by Josef S Smolen, Robert Landewé, Ferdinand C Breedveld +44 · 37 citations
Immunology and Microbiology · Medicine · #Abatacept #Adalimumab #Antirheumatic Agents #Antirheumatic drugs #Biosimilars and Bioanalytical Methods #Certolizumab pegol #Disease #Etanercept #Golimumab #Infliximab #Intensive care medicine #Internal medicine #Lymphoma Diagnosis and Treatment #Medicine #Physical therapy #Rheumatism #Rheumatoid Arthritis Research and Therapies #Rheumatoid arthritis #Rituximab #Tocilizumab
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
2020/01/22 by Josef S Smolen, Robert Landewé, Robert B M Landewé +62 · 33 citations
Immunology and Microbiology · Medicine · #Antirheumatic Agents #Antirheumatic drugs #Arthritis #Biological drugs #Biosimilars and Bioanalytical Methods #Disease #Disease management #Intensive care medicine #Internal medicine #Medicine #Physical therapy #Rheumatoid Arthritis Research and Therapies #Rheumatoid arthritis #Systemic Lupus Erythematosus Research
- Effects of glucocorticoids on radiological progression in rheumatoid arthritis
2007/01/24 by John Kirwan, J. W. J. Bijlsma, Maarten Boers +1 · 1 citation
Medicine · #Rheumatoid Arthritis Research and Therapies #Bone and Joint Diseases #Systemic Sclerosis and Related Diseases